Feb 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 1: Current Management Approaches for Patients with Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD  

CME information and select publications

Feb 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 2: Future Directions in the Care of Patients with CLL — Lindsey Roeker, MD

CME information and select...

Feb 27, 2024

Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman, including the following topics:

• An Audio Depiction of Mechanisms of Action of Bcl-2 Inhibitors, Anti-CD20 Antibodies and Covalent and Noncovalent Bruton Tyrosine Kinase Inhibitors; Mechanisms of Resistance (0:00)
• Current Management Approaches for...

Feb 23, 2024

Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel, including the following topics:

• Introduction: EMERALD-1 — Immune Checkpoint Inhibitor-Based Therapy for Localized HCC Eligible for Embolization (0:00)
• Optimal Utilization of Immune Checkpoint Inhibitors as First-Line Therapy for Advanced HCC – Dr...

Feb 20, 2024

Featuring perspectives from Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Dr Elisabeth I Heath and Dr A Oliver Sartor, moderated by Dr Alan H Bryce, including the following topics:

• Introduction (0:00)
• Optimizing the Management of Nonmetastatic Prostate Cancer — Dr Aggarwal (1:51)
• Evidence-Based Selection of Treatment...